ClonOrgan
Chengdu
About ClonOrgan
ClonOrgan has developed a technology to humanize pig cells that will grow into human-compatible organs. The business specializes in xenotransplantation and has a one-stop R&D platform that includes raising gene-edited pigs, preclinical testing, and breeding. It is dedicated to addressing the critical shortage of clinical organ transplantation and creating the organ factory of the future. ClonOrgas was established in 2005 in Chengdu, Sichuan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: clonorgan.com
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Medical
Canonical: https://fsome.com/organization/clonorgan-110764 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.